Efficacy and Safety of Indacaterol/Glycopyrronium/Mometasone Furoate in Patients with Uncontrolled Asthma- The Phase III IRIDIUM Study

13 Jun 2020
pdf
Abstract - Efficacy and Safety of Indacaterol/Glycopyrronium/Mometasone Furoate in Patients with Uncontrolled Asthma
412.41 KB
pdf
Presentation - Efficacy and Safety of Indacaterol/Glycopyrronium/Mometasone Furoate in Patients with Uncontrolled Asthma
556.07 KB

Resource information

Respiratory conditions
  • Asthma
Respiratory topics
  • Treatment - drug
  • Disease management
Type of resource
Abstract
Conference
2020 Virtual Conferences
Author(s)
Huib A. M. Kerstjens1, Jorge F. Maspero2, Kenneth R. Chapman3, Richard van Zyl-Smit4, Karen Mezzi5, Ivan Nikolaev5, Motoi Hosoe5, Ana-Maria Tanase5, Catherine Lavecchia6, Abhijit Pethe6, Xu Shu6, Peter D’Andrea6 1University Medical Center Groningen, Groningen, The Netherlands, 2Allergy and Respiratory Research Unit, Fundación CIDEA, Buenos Aires, Argentina, 3Division of Respiratory Medicine, Department of Medicine, University of Toronto, Toronto, Ontario, Canada, 4Division of Pulmonology and UCT Lung Institute, University of Cape Town, Cape Town, South Africa, 5Novartis Pharma AG, Basel, Switzerland, 6Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States